Mahoney Stephen F. 4
4 · Kiniksa Pharmaceuticals, Ltd. · Filed Sep 19, 2019
Insider Transaction Report
Form 4
Mahoney Stephen F.
President & COO10% Owner
Transactions
- Award
Share Option
2019-09-17+82,000→ 82,000 totalExercise: $8.83Exp: 2029-09-16→ Class A Common Shares (82,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in thirty-six equal monthly installments thereafter. The vesting commencement date is September 17, 2019.